GSK & Sanofi’s Unprecedented COVID-19 Vaccine Collaboration
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are working together to develop a vaccine for the novel coronavirus (COVID-19);…
Business Solutions is the team of experts at Disneyland Paris, dedicated to organizing large venue events for companies, conferences, and congresses. Disneyland Paris is a unique venue and now the largest all-in-one destination for business tourism in Europe. With its own rail terminal, state-of-the-art congress centers, hotels, restaurants and a huge range of activities on offer, Disneyland Paris offers everything a company may need to make an event an outstanding success! With a staff of 150, Disney Business Solutions has a team of specialists ready to customize any type of event in the various Disneyland Paris venues available for events, including plenary rooms or exhibition areas. With a series of hotels and restaurants nearby, all event attendees are in a close, easily navigable site, also in proximity to the amenities of Disneyland Paris’ two theme parks. The venue is conveniently reached by all modes of transportation including local and regional trains (RER and Eurostar), shuttles from both Charles de Gaulle airport and Orly Airport, as well as a mere 35 minutes drive from Paris.
Contact
+33 160 457 500
Euro Disney Associes S.C.A.
Business Solutions
Boite Postale 112
F-77777 Marne-la-Vallee Cedex 4
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are working together to develop a vaccine for the novel coronavirus (COVID-19);…
Speaking exclusively to PharmaBoardroom at the International Women’s Day 2020 event at the Franco-British Chamber of Commerce in Paris, esteemed cardiologist Professor Claire Mounier-Vehier outlines why cardiovascular disease is not…
Researchers at the Institut Pasteur in Paris have become the first in Europe to fully sequence the genome of the 2019-nCoV coronavirus – putting the Institut at the forefront of…
These are worrying times for iconic French mid-cap Ipsen. Trials for palovarotene, a treatment for rare bone disorders, have been plagued by setbacks, perhaps contributing to erstwhile CEO David Meek’s…
France is home to the highest rates of vaccine mistrust in Europe, with a third of French people disagreeing that vaccines are safe, according to the Wellcome Global Monitor survey.…
With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on data” and eccentric mathematician Cédric Villani, well in the process of drawing…
France – one of the most influential countries in the development of gene therapy– still stands as a global powerhouse in the field, with top-class institutions, a dense network of…
With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma standard-bearers are once more on the rise. These medium-sized national champions form part of G5 Santé, a…
Francois Cornu, president of Eurofins Biomnis, and Gautier Decock, managing director of Eurofins BioPharma Product Testing in France and Belgium, come together to shed light on the company’s unique decentralized…
Nathalie Giraud, director of integrated monitoring investigator services & head of France at PPD, breaks down the strengths and weaknesses of the French clinical trials environment and stresses the importance…
The latest issue of Healthcare & Life Sciences Review France follows on from our March 2019 report and takes a closer look at the wider French life sciences value chain…
Not long ago, Laboratories Servier was considered a somewhat mysterious and opaque actor on the world pharmaceuticals stage. Privately owned, smaller and sleeker than many of its direct competitors, but…
See our Cookie Privacy Policy Here
